Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study

• Published in: BMC neurology Vol. 10; no. 1; p. 10
• Main Authors: Boles, Richard G, Lovett-Barr, Mary R, Preston, Amy, Li, B UK, Adams, Kathleen
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28.01.2010; BioMed Central; BMC
• Subjects: Age of Onset; Amitriptyline; Amitriptyline - adverse effects; Amitriptyline - therapeutic use; Antiemetics - adverse effects; Antiemetics - therapeutic use; Clinical medicine; Clinical trials; Drug therapy; Failure; Headaches; Health aspects; Humans; Internet; Migraine; Mitochondrial DNA; Parents; Patient Satisfaction; Pediatrics; Periodicity; Physicians; Research article; Retrospective Studies; Risk Assessment; Surveys; Syndrome; Treatment Outcome; Ubiquinone - adverse effects; Ubiquinone - analogs & derivatives; Ubiquinone - therapeutic use; Vomiting; Vomiting - drug therapy; United States

Cyclic vomiting syndrome (CVS), which is defined by recurrent stereotypical episodes of nausea and vomiting, is a relatively-common disabling condition that is associated with migraine headache and mitochondrial dysfunction. Co-enzyme Q10 (Co-Q) is a nutritional supplement that has demonstrated effi...